NIR fluorophores clinically assessed for fluorescence guided surgery

10 October 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The term “fluorescence” was first proposed nearly two centuries ago, yet its application in Medicine has a relatively brief history of only 70 years. Nowadays, as fluorescence was gradually approaching into more medicine studies, fluorescence image-guided surgery has become the new arena for this technology. It allows surgeons to real-time visualize the target structure intraoperatively to increase the efficacy of surgical tissue resection and meanwhile avoid unnecessary radical treatment during open surgery, laparoscopy, thoracoscopy, or endoscopes. In this review, we introduce the concept of near-infrared fluorescence imaging for cancer surgery, review the clinical trial literature to date, outline the key issues pertaining to imaging system and contrast agent optimization, discuss limitations and leverage, and provide a framework for making the technology available for the routine care of cancer patients in the near future.

Keywords

fluorescence
surgery

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.